Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morningstar (MORN) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Morningstar (MORN) over the last 17 years, with Q4 2025 value amounting to $2.6 million.

  • Morningstar's Asset Writedowns and Impairment rose 4444.44% to $2.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 million, marking a year-over-year decrease of 3703.7%. This contributed to the annual value of $5.1 million for FY2025, which is 3703.7% down from last year.
  • Morningstar's Asset Writedowns and Impairment amounted to $2.6 million in Q4 2025, which was up 4444.44% from $600000.0 recorded in Q3 2025.
  • In the past 5 years, Morningstar's Asset Writedowns and Impairment registered a high of $3.1 million during Q2 2024, and its lowest value of -$600000.0 during Q2 2025.
  • Over the past 5 years, Morningstar's median Asset Writedowns and Impairment value was $1.3 million (recorded in 2022), while the average stood at $1.3 million.
  • In the last 5 years, Morningstar's Asset Writedowns and Impairment soared by 180000.0% in 2022 and then tumbled by 11935.48% in 2025.
  • Morningstar's Asset Writedowns and Impairment (Quarter) stood at -$100000.0 in 2021, then surged by 1800.0% to $1.7 million in 2022, then changed by 0.0% to $1.7 million in 2023, then increased by 5.88% to $1.8 million in 2024, then skyrocketed by 44.44% to $2.6 million in 2025.
  • Its Asset Writedowns and Impairment stands at $2.6 million for Q4 2025, versus $600000.0 for Q3 2025 and -$600000.0 for Q2 2025.